Glück Conviction Score™ ⓘ
DNTH
Dianthus Therapeutics, Inc. /DE/
Effektiv: Neutral
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
82,4
92 neu, 82 erhöht, 2903,7M $ netto
Aktivist
23,6
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 87.18 | -5.9 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 56.31 | +45.7 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 83.81 | EMA50: 83.02 | |
| MACD-Histogramm | Bärisch | 10 % | -0.873 | Bearisch | |
| RSI(14) | Neutral | 10 % | 46.9 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 53.4 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 20.7 | +DI: 14.2 / −DI: 24.0 | |
| Z-Score(60) | Neutral | 5 % | -0.89 | In Range | |
| 52W-Position | Bullisch | 5 % | 82.6 % | Hoch 95.76 / Tief 16.86 | |
| Bollinger(20,2σ) | Neutral | 5 % | 33.2 % | Upper 93.53 / Mid 84.95 / Lower 76.37 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.0014 | R²=0.00 / annualisiert -0.4 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | Randhawa Simrat | Officer, EVP, Head of R&D | Open Market Sale | -16.943 | 90,72 | -1.537.068,96 | -122,3% | |
| 2026-06-01 | Randhawa Simrat | Officer, EVP, Head of R&D | Open Market Sale | -4.159 | 91,37 | -380.007,83 | -30,2% | |
| 2026-06-01 | Randhawa Simrat | Officer, EVP, Head of R&D | Open Market Sale | -5.428 | 89,72 | -487.000,16 | -38,8% | |
| 2026-05-08 | Soteropoulos Paula | Director | Open Market Sale | -599 | 85,47 | -51.196,53 | -4,1% | |
| 2026-04-09 | Savitz Ryan | Officer, EVP, CFO & CBO | Open Market Sale | -8.224 | 89,84 | -738.844,16 | -58,8% | |
| 2026-03-31 | Savitz Ryan | Officer, EVP, CFO & CBO | Open Market Sale | -59.800 | 83,90 | -5.017.220,00 | -399,3% | |
| 2026-03-31 | Savitz Ryan | Officer, EVP, CFO & CBO | Open Market Sale | -1.485 | 80,25 | -119.171,25 | -9,5% | |
| 2026-03-31 | Savitz Ryan | Officer, EVP, CFO & CBO | Open Market Sale | -2.366 | 82,84 | -195.999,44 | -15,6% | |
| 2026-03-31 | Savitz Ryan | Officer, EVP, CFO & CBO | Open Market Sale | -7.232 | 85,54 | -618.625,28 | -49,2% | |
| 2026-03-31 | Savitz Ryan | Officer, EVP, CFO & CBO | Open Market Sale | -19.469 | 84,57 | -1.646.493,33 | -131,1% | |
| 2026-03-31 | Savitz Ryan | Officer, EVP, CFO & CBO | Open Market Sale | -21.825 | 78,86 | -1.721.119,50 | -137,0% | |
| 2026-03-31 | Savitz Ryan | Officer, EVP, CFO & CBO | Open Market Sale | -800 | 81,36 | -65.088,00 | -5,2% | |
| 2026-03-31 | Soteropoulos Paula | Director | Open Market Sale | -599 | 80,11 | -47.985,89 | -3,8% | |
| 2026-03-31 | Savitz Ryan | Officer, EVP, CFO & CBO | Open Market Sale | -1.390 | 78,33 | -108.878,70 | -8,7% | |
| 2026-03-24 | Soteropoulos Paula | Director | Open Market Sale | -27.594 | 78,05 | -2.153.711,70 | -171,4% | |
| 2026-03-12 | Randhawa Simrat | Officer, EVP, Head of R&D | Open Market Sale | -33.830 | 81,48 | -2.756.468,40 | -219,4% | |
| 2026-03-12 | CARR EDWARD | Officer, CHIEF ACCOUNTING OFFICER | Open Market Sale | -200 | 83,38 | -16.676,00 | -1,3% | |
| 2026-03-12 | CARR EDWARD | Officer, CHIEF ACCOUNTING OFFICER | Open Market Sale | -300 | 85,53 | -25.659,00 | -2,0% | |
| 2026-03-12 | CARR EDWARD | Officer, CHIEF ACCOUNTING OFFICER | Open Market Sale | -3.865 | 82,66 | -319.480,90 | -25,4% | |
| 2026-03-12 | CARR EDWARD | Officer, CHIEF ACCOUNTING OFFICER | Open Market Sale | -15.852 | 80,71 | -1.279.414,92 | -101,8% | |
| 2026-03-12 | CARR EDWARD | Officer, CHIEF ACCOUNTING OFFICER | Open Market Sale | -23.465 | 81,75 | -1.918.263,75 | -152,7% | |
| 2026-03-12 | Garcia Marino | Director, Officer, CEO AND PRESIDENT | Open Market Sale | -200 | 83,38 | -16.676,00 | -1,3% | |
| 2026-03-12 | Garcia Marino | Director, Officer, CEO AND PRESIDENT | Open Market Sale | -900 | 85,53 | -76.977,00 | -6,1% | |
| 2026-03-12 | Garcia Marino | Director, Officer, CEO AND PRESIDENT | Open Market Sale | -12.796 | 82,60 | -1.056.949,60 | -84,1% | |
| 2026-03-12 | Garcia Marino | Director, Officer, CEO AND PRESIDENT | Open Market Sale | -43.505 | 80,69 | -3.510.418,45 | -279,4% | |
| 2026-03-12 | Garcia Marino | Director, Officer, CEO AND PRESIDENT | Open Market Sale | -65.517 | 81,74 | -5.355.359,58 | -426,3% | |
| 2025-12-04 | Savitz Ryan | Officer, CFO & CBO | Open Market Sale | -20.000 | 45,18 | -903.600,00 | -71,9% | |
| 2025-11-14 | Randhawa Simrat | Officer, EVP, Head of R&D | Open Market Sale | -109.031 | 38,14 | -4.158.442,34 | -331,0% | |
| 2025-11-13 | Randhawa Simrat | Officer, EVP, Head of R&D | Open Market Sale | -42.765 | 37,04 | -1.584.015,60 | -126,1% | |
| 2025-11-13 | Randhawa Simrat | Officer, EVP, Head of R&D | Open Market Sale | -26.166 | 35,80 | -936.742,80 | -74,6% | |
| 2025-11-13 | Randhawa Simrat | Officer, EVP, Head of R&D | Open Market Sale | -18.576 | 37,72 | -700.686,72 | -55,8% | |
| 2025-09-09 | Savitz Ryan | Officer, CFO & CBO | Open Market Sale | -20.000 | 35,00 | -700.000,00 | -55,7% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| FMR LLC | 7.767.686 | 6.431.329 | 1.336.357 | 651.864.210 | Aufgestockt | +20,8% | |
| BlackRock, Inc. | 3.175.703 | 1.915.236 | 1.260.467 | 266.504.995 | Aufgestockt | +65,8% | |
| RA CAPITAL MANAGEMENT, L.P. | 2.611.733 | 1.611.733 | 1.000.000 | 219.176.633 | Aufgestockt | +62,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 2.595.783 | 2.503.190 | 92.593 | 217.838.110 | Aufgestockt | +3,7% | |
| Fairmount Funds Management LLC | 2.537.191 | 2.137.191 | 400.000 | 212.921.069 | Aufgestockt | +18,7% | |
| Avidity Partners Management LP | 2.104.184 | 2.104.184 | 0 | 176.583.121 | Unverändert | 0,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.031.249 | 0 | 2.031.249 | 170.462.416 | Neu | +100,0% | |
| Octagon Capital Advisors LP | 1.946.667 | 2.416.667 | -470.000 | 163.364.295 | Reduziert | -19,4% | |
| TCG Crossover Management, LLC | 1.676.624 | 1.676.624 | 0 | 140.702.286 | Unverändert | 0,0% | |
| CITADEL ADVISORS LLC | 1.648.983 | 1.079.734 | 569.249 | 138.382.653 | Aufgestockt | +52,7% | |
| STATE STREET CORP | 1.398.913 | 1.507.619 | -108.706 | 117.396.779 | Reduziert | -7,2% | |
| Venrock Adviser, LLC | 1.180.000 | 1.000.000 | 180.000 | 99.025.600 | Aufgestockt | +18,0% | |
| FRED ALGER MANAGEMENT, LLC | 1.161.923 | 33.460 | 1.128.463 | 97.508.578 | Aufgestockt | +3372,6% | |
| Polar Capital Holdings Plc | 1.076.009 | 1.004.728 | 71.281 | 90.298.675 | Aufgestockt | +7,1% | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.019.813 | 0 | 1.019.813 | 85.582.707 | Neu | +100,0% | |
| VANGUARD GROUP INC | 2.048.452 | 0 | 2.048.452 | 84.416.707 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 968.182 | 462.826 | 505.356 | 81.249.867 | Aufgestockt | +109,2% | |
| Cormorant Asset Management, LP | 950.000 | 0 | 950.000 | 79.724.000 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 916.211 | 676.658 | 239.553 | 76.904.871 | Aufgestockt | +35,4% | |
| BRAIDWELL LP | 899.364 | 1.273.935 | -374.571 | 75.474.627 | Reduziert | -29,4% | |
| BAKER BROS. ADVISORS LP | 852.164 | 789.759 | 62.405 | 71.513.603 | Aufgestockt | +7,9% | |
| FARALLON CAPITAL MANAGEMENT LLC | 836.000 | 0 | 836.000 | 70.157.120 | Neu | +100,0% | |
| UBS Group AG | 781.282 | 606.620 | 174.662 | 65.565.185 | Aufgestockt | +28,8% | |
| SILVERARC CAPITAL MANAGEMENT, LLC | 654.746 | 750.136 | -95.390 | 54.946.284 | Reduziert | -12,7% | |
| Point72 Asset Management, L.P. | 643.599 | 1.166.088 | -522.489 | 54.010.828 | Reduziert | -44,8% | |
| Catalio Capital Management, LP | 560.308 | 653.572 | -93.264 | 47.021.047 | Reduziert | -14,3% | |
| GOLDMAN SACHS GROUP INC | 548.010 | 577.019 | -29.009 | 45.988.999 | Reduziert | -5,0% | |
| JENNISON ASSOCIATES LLC | 485.136 | 0 | 485.136 | 40.712.614 | Neu | +100,0% | |
| BALYASNY ASSET MANAGEMENT L.P. | 474.085 | 0 | 474.085 | 39.785.213 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 926.071 | 834.383 | 91.688 | 38.163.386 | Aufgestockt | +11,0% | |
| Woodline Partners LP | 433.457 | 213.087 | 220.370 | 36.375.711 | Aufgestockt | +103,4% | |
| SAMLYN CAPITAL, LLC | 431.115 | 0 | 431.115 | 36.179.171 | Neu | +100,0% | |
| MPM BioImpact LLC | 423.982 | 0 | 423.982 | 35.580.569 | Neu | +100,0% | |
| Affinity Asset Advisors, LLC | 400.000 | 115.000 | 285.000 | 33.568.000 | Aufgestockt | +247,8% | |
| Logos Global Management LP | 400.000 | 315.000 | 85.000 | 33.568.000 | Aufgestockt | +27,0% | |
| Artisan Partners Limited Partnership | 382.121 | 0 | 382.121 | 32.067.594 | Neu | +100,0% | |
| BARCLAYS PLC | 379.606 | 176.300 | 203.306 | 31.856.536 | Aufgestockt | +115,3% | |
| Spruce Street Capital LP | 373.274 | 297.437 | 75.837 | 31.325.154 | Aufgestockt | +25,5% | |
| Sio Capital Management, LLC | 370.045 | 474.503 | -104.458 | 31.054.176 | Reduziert | -22,0% | |
| Bain Capital Life Sciences Investors, LLC | 362.470 | 743.592 | -381.122 | 30.418.482 | Reduziert | -51,3% | |
| AMERIPRISE FINANCIAL INC | 358.470 | 155.163 | 203.307 | 30.082.981 | Aufgestockt | +131,0% | |
| Vivo Capital, LLC | 353.998 | 353.998 | 0 | 29.707.512 | Unverändert | 0,0% | |
| MARSHALL WACE, LLP | 341.929 | 1.008.533 | -666.604 | 28.694.682 | Reduziert | -66,1% | |
| DIMENSIONAL FUND ADVISORS LP | 325.440 | 210.673 | 114.767 | 27.296.491 | Aufgestockt | +54,5% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 317.312 | 0 | 317.312 | 26.628.823 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 305.440 | 250.812 | 54.628 | 25.632.525 | Aufgestockt | +21,8% | |
| NORTHERN TRUST CORP | 303.752 | 207.246 | 96.506 | 25.490.868 | Aufgestockt | +46,6% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 287.201 | 92.566 | 194.635 | 24.101.908 | Aufgestockt | +210,3% | |
| TANG CAPITAL MANAGEMENT LLC | 264.692 | 264.692 | 0 | 22.212.953 | Unverändert | 0,0% | |
| MILLENNIUM MANAGEMENT LLC | 261.962 | 667.216 | -405.254 | 21.983.851 | Reduziert | -60,7% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| FMR LLC | 7.767.686 | 6.431.329 | +20,8% | 651.864.210 | 13,34 |
| BlackRock, Inc. | 3.175.703 | 1.915.236 | +65,8% | 266.504.995 | 5,45 |
| RA CAPITAL MANAGEMENT, L.P. | 2.611.733 | 1.611.733 | +62,0% | 219.176.633 | 4,49 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.595.783 | 2.503.190 | +3,7% | 217.838.110 | 4,46 |
| Fairmount Funds Management LLC | 2.537.191 | 2.137.191 | +18,7% | 212.921.069 | 4,36 |
| Avidity Partners Management LP | 2.104.184 | 2.104.184 | 0,0% | 176.583.121 | 3,61 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.031.249 | 0 | +100,0% | 170.462.416 | 3,49 |
| Octagon Capital Advisors LP | 1.946.667 | 2.416.667 | -19,4% | 163.364.295 | 3,34 |
| TCG Crossover Management, LLC | 1.676.624 | 1.676.624 | 0,0% | 140.702.286 | 2,88 |
| CITADEL ADVISORS LLC | 1.648.983 | 1.079.734 | +52,7% | 138.382.653 | 2,83 |
| STATE STREET CORP | 1.398.913 | 1.507.619 | -7,2% | 117.396.779 | 2,40 |
| Venrock Adviser, LLC | 1.180.000 | 1.000.000 | +18,0% | 99.025.600 | 2,03 |
| FRED ALGER MANAGEMENT, LLC | 1.161.923 | 33.460 | +3372,6% | 97.508.578 | 2,00 |
| Polar Capital Holdings Plc | 1.076.009 | 1.004.728 | +7,1% | 90.298.675 | 1,85 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.019.813 | 0 | +100,0% | 85.582.707 | 1,75 |
| FRANKLIN RESOURCES INC | 968.182 | 462.826 | +109,2% | 81.249.867 | 1,66 |
| Cormorant Asset Management, LP | 950.000 | 0 | +100,0% | 79.724.000 | 1,63 |
| GEODE CAPITAL MANAGEMENT, LLC | 916.211 | 676.658 | +35,4% | 76.904.871 | 1,57 |
| BRAIDWELL LP | 899.364 | 1.273.935 | -29,4% | 75.474.627 | 1,54 |
| BAKER BROS. ADVISORS LP | 852.164 | 789.759 | +7,9% | 71.513.603 | 1,46 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 241 | 67,5 | 5.397 |
| 31.12.2025 | ✓ | 164 | 50,0 | 2.029 |
| 30.09.2025 | ✓ | 141 | 48,1 | 1.885 |
| 30.06.2025 | ✓ | 102 | 39,5 | 731 |
| 31.03.2025 | ✓ | 97 | 41,8 | 758 |
| 31.12.2024 | ✓ | 93 | 35,3 | 767 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Spruce Street Capital LP | 297.437 | 12.257.379 |
| ExodusPoint Capital Management, LP | 246.788 | 10.170.133 |
| Iron Triangle Partners LP | 230.730 | 9.508.383 |
| Squarepoint Ops LLC | 207.119 | 8.535.374 |
| Atika Capital Management LLC | 134.528 | 5.543.899 |
| SummitTX Capital, L.P. | 87.926 | 3.623.430 |
| Neuberger Berman Group LLC | 87.782 | 3.617.496 |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 48.477 | 1.997.737 |
| TWO SIGMA INVESTMENTS, LP | 48.400 | 1.994.564 |
| Cinctive Capital Management LP | 45.906 | 1.891.786 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| STATE STREET CORP | 1.507.619 | 836.571 | +124.7 % | 62.128.979 |
| BlackRock, Inc. | 1.915.236 | 575.145 | +42.9 % | 78.926.876 |
| MILLENNIUM MANAGEMENT LLC | 667.216 | 521.050 | +356.5 % | 27.495.971 |
| UBS Group AG | 606.620 | 469.547 | +342.6 % | 24.998.811 |
| FMR LLC | 6.431.329 | 460.691 | +7.7 % | 265.035.068 |
| BNP PARIBAS FINANCIAL MARKETS | 475.749 | 441.156 | +1275.3 % | 19.605.616 |
| Tri Locum Partners LP | 622.403 | 439.536 | +240.4 % | 25.649.228 |
| BRAIDWELL LP | 1.273.935 | 438.878 | +52.6 % | 52.498.861 |
| MARSHALL WACE, LLP | 1.008.533 | 435.595 | +76.0 % | 41.561.643 |
| VANGUARD GROUP INC | 2.048.452 | 406.254 | +24.7 % | 84.416.707 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 1.611.733 | -1.255.000 | -43.8 % | 66.419.517 |
| Fairmount Funds Management LLC | 2.137.191 | -1.170.000 | -35.4 % | 88.073.641 |
| Avidity Partners Management LP | 2.104.184 | -1.100.000 | -34.3 % | 86.713.423 |
| Point72 Asset Management, L.P. | 1.166.088 | -875.872 | -42.9 % | 48.054.486 |
| Bain Capital Life Sciences Investors, LLC | 743.592 | -572.300 | -43.5 % | 30.643.426 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 92.566 | -234.895 | -71.7 % | 3.814.645 |
| Affinity Asset Advisors, LLC | 115.000 | -147.100 | -56.1 % | 4.739.150 |
| JANE STREET GROUP, LLC | 45.833 | -122.167 | -72.7 % | 1.888.778 |
| Sio Capital Management, LLC | 474.503 | -103.247 | -17.9 % | 19.554.269 |
| Rhenman & Partners Asset Management AB | 98.627 | -75.000 | -43.2 % | 4.064.419 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 15.05.2026 | Rajeev Shah | Passiv (13G/A) | 4,80 % | 2.611.733 | -1,20 pp | |
| 15.05.2026 | RA Capital Management, L.P. | Passiv (13G/A) | 4,80 % | 2.611.733 | -1,20 pp | |
| 15.05.2026 | Peter Kolchinsky | Passiv (13G/A) | 4,80 % | 2.611.733 | -1,20 pp | |
| 15.05.2026 | RA Capital Healthcare Fund, L.P. | Passiv (13G/A) | 4,80 % | 2.611.733 | -1,20 pp | |
| 15.05.2026 | Steven A. Cohen | Passiv (13G/A) | 1,20 % | 643.599 | -5,70 pp | |
| 15.05.2026 | Point72 Asset Management, L.P. | Passiv (13G/A) | 1,20 % | 643.599 | -5,70 pp | |
| 15.05.2026 | Point72 Capital Advisors, Inc. | Passiv (13G/A) | 1,20 % | 643.599 | -5,70 pp | |
| 15.05.2026 | Alex Silverstein | Passiv (13G) | 5,30 % | 2.798.122 | Neu | |
| 15.05.2026 | Sirenia Capital Management LP | Passiv (13G) | 5,30 % | 2.798.122 | Neu | |
| 15.05.2026 | Wellington Investment Advisors Holdings LLP | Passiv (13G/A) | 4,80 % | 2.595.783 | -1,70 pp | |
| 15.05.2026 | Wellington Management Group LLP | Passiv (13G/A) | 4,80 % | 2.595.783 | -1,70 pp | |
| 15.05.2026 | Wellington Group Holdings LLP | Passiv (13G/A) | 4,80 % | 2.595.783 | -1,70 pp | |
| 14.05.2026 | Octagon Biotech Opportunities Fund I LP | Passiv (13G/A) | 0,60 % | 291.667 | Neu | |
| 14.05.2026 | Octagon Investments Master Fund LP | Passiv (13G/A) | 3,00 % | 1.655.000 | -2,30 pp | |
| 14.05.2026 | Octagon Capital Advisors LP | Passiv (13G/A) | 3,60 % | 1.946.667 | -2,50 pp | |
| 14.05.2026 | Ting Jia | Passiv (13G/A) | 3,60 % | 1.946.667 | -2,50 pp | |
| 27.04.2026 | BlackRock, Inc. | Passiv (13G) | 5,10 % | 2.634.004 | +0,10 pp | |
| 17.02.2026 | RA Capital Management, L.P. | Passiv (13G/A) | 6,00 % | 2.611.733 | -3,50 pp | |
| 17.02.2026 | RA Capital Healthcare Fund, L.P. | Passiv (13G/A) | 6,00 % | 2.611.733 | -3,50 pp | |
| 17.02.2026 | Peter Kolchinsky | Passiv (13G/A) | 6,00 % | 2.611.733 | -3,50 pp | |
| 17.02.2026 | Rajeev Shah | Passiv (13G/A) | 6,00 % | 2.611.733 | -3,50 pp | |
| 17.02.2026 | Point72 Capital Advisors, Inc. | Passiv (13G/A) | 6,90 % | 2.981.674 | +1,60 pp | |
| 17.02.2026 | Point72 Asset Management, L.P. | Passiv (13G/A) | 6,90 % | 2.981.674 | +1,60 pp | |
| 17.02.2026 | Steven A. Cohen | Passiv (13G/A) | 6,90 % | 2.981.674 | +1,60 pp | |
| 25.11.2025 | Fairmount Funds Management LLC | Aktivist (13D/A) | 4,90 % | 2.139.635 | -5,00 pp | Item 4 of the Statement is hereby amended and supplemented as follows: On November 24, … |
| 25.11.2025 | Fairmount Healthcare Fund II L.P. | Aktivist (13D/A) | 4,90 % | 2.139.635 | -5,00 pp | Item 4 of the Statement is hereby amended and supplemented as follows: On November 24, … |
| 25.11.2025 | Tomas Kiselak | Aktivist (13D/A) | 4,90 % | 2.139.635 | -5,00 pp | Item 4 of the Statement is hereby amended and supplemented as follows: On November 24, … |
| 25.11.2025 | Peter Evan Harwin | Aktivist (13D/A) | 4,90 % | 2.139.635 | -5,00 pp | Item 4 of the Statement is hereby amended and supplemented as follows: On November 24, … |
| 19.11.2025 | Avidity Capital Partners (GP) LLC | Aktivist (13D/A) | 4,90 % | 2.104.184 | -5,00 pp | The Reporting Persons are filing this Amendment No. 3 to report a greater than 1.00% dec… |
| 19.11.2025 | Avidity Capital Partners Fund (GP) LP | Aktivist (13D/A) | 4,90 % | 2.104.184 | -5,00 pp | The Reporting Persons are filing this Amendment No. 3 to report a greater than 1.00% dec… |
| 19.11.2025 | Michael Gregory | Aktivist (13D/A) | 4,90 % | 2.104.184 | -5,00 pp | The Reporting Persons are filing this Amendment No. 3 to report a greater than 1.00% dec… |
| 19.11.2025 | Avidity Private Master Fund I LP | Aktivist (13D/A) | 4,40 % | 1.899.593 | -3,90 pp | The Reporting Persons are filing this Amendment No. 3 to report a greater than 1.00% dec… |
| 19.11.2025 | Avidity Partners Management LP | Aktivist (13D/A) | 4,90 % | 2.104.184 | -5,00 pp | The Reporting Persons are filing this Amendment No. 3 to report a greater than 1.00% dec… |
| 19.11.2025 | Avidity Partners Management (GP) LLC | Aktivist (13D/A) | 4,90 % | 2.104.184 | -5,00 pp | The Reporting Persons are filing this Amendment No. 3 to report a greater than 1.00% dec… |
| 14.11.2025 | Peter Kolchinsky | Passiv (13G/A) | 9,50 % | 3.866.733 | +0,60 pp | |
| 14.11.2025 | RA Capital Healthcare Fund, L.P. | Passiv (13G/A) | 9,50 % | 3.866.733 | +0,60 pp | |
| 14.11.2025 | Rajeev Shah | Passiv (13G/A) | 9,50 % | 3.866.733 | +0,60 pp | |
| 14.11.2025 | RA Capital Management, L.P. | Passiv (13G/A) | 9,50 % | 3.866.733 | +0,60 pp | |
| 14.11.2025 | Octagon Capital Advisors LP | Passiv (13G/A) | 6,10 % | 2.416.667 | -1,00 pp | |
| 14.11.2025 | Octagon Private Opportunities Fund II LP | Passiv (13G/A) | 0,70 % | 291.667 | -0,30 pp |
Stammdaten
Dianthus Therapeutics, Inc. agiert als Biotechnologie-Unternehmen in klinischer Phase, das neuartige monoklonale Antikörper für Menschen mit schweren Autoimmun- und Entzündungskrankheiten konzipiert, entwickelt und liefert. Es entwickelt DNTH103, das sich in Phase-1-Kliniktests bei Patienten mit generalisierter Myasthenia Gravis, multifokaler motorischer Neuropathie und chronisch entzündlicher demyelinisierender Polyneuropathie befindet. Dianthus Therapeutics, Inc. wurde 2015 gegründet und hat seinen Sitz in New York, New York.
Unternehmen & Branche
| Name | Dianthus Therapeutics, Inc. /DE/ |
|---|---|
| Ticker | DNTH |
| CIK | 0001690585 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 252828108 |
|---|---|
| ISIN | US2528281080 |
| Typ | Common Stock |
| Marktkapitalisierung | 3,30 Mrd. USD |
| Beta | 1,16 |
| Dividendenrendite | 0,00 % |
Bewertung
| KBV (P/B) | 6,70 |
|---|---|
| KUV (P/S) | 1.622,99 |
| FCF-Rendite | -3,9 % vs. -1,5 % (2021) ▼ |
Qualität & Bilanz
| Operative Marge | -8.739,3 % |
|---|---|
| Nettomarge | -7.973,3 % |
| ROIC | -32,8 % |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | – | – | 0,91 | 1,92 | 3,61 | |
| KUV (P/S) | – | – | 54,53 | 108,79 | 874,86 | |
| FCF-Rendite | -1,5 % | -531,2 % | -23,9 % | -11,5 % | -7,2 % | |
| Qualität & Bilanz | ||||||
| Operative Marge | – | – | -1.704,7 % | -1.633,7 % | -8.739,3 % | |
| Nettomarge | – | – | -1.541,2 % | -1.362,8 % | -7.973,3 % | |
| ROIC | – | – | -25,7 % | -24,0 % | -32,8 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -40.834.000 | -0,85 | 1.246.884.000 | 1.201.314.000 | |
| 2025-12-31 | 10-K | 2.036.000 | -162.337.000 | -4,20 | 530.922.000 | 493.401.000 |
| 2025-09-30 | 10-Q | 396.000 | -36.765.000 | -0,97 | 577.445.000 | 546.454.000 |
| 2025-06-30 | 10-Q | 193.000 | -31.629.000 | -0,88 | 326.076.000 | 303.079.000 |
| 2025-03-31 | 10-Q | 1.163.000 | -29.511.000 | -0,82 | 348.580.000 | 328.606.000 |
| 2024-12-31 | 10-K | 6.235.000 | -84.969.000 | -2,55 | 374.008.000 | 352.477.000 |
| 2024-09-30 | 10-Q | 2.172.000 | -25.174.000 | -0,74 | 354.248.000 | 337.898.000 |
| 2024-06-30 | 10-Q | 1.863.000 | -17.607.000 | -0,51 | 368.959.000 | 358.218.000 |
| 2024-03-31 | 10-Q | 874.000 | -13.748.000 | -0,54 | 382.462.000 | 372.687.000 |
| 2023-12-31 | 10-K | 2.826.000 | -43.555.000 | -8,45 | 179.405.000 | 168.870.000 |
| 2023-09-30 | 10-Q | 924.000 | -14.763.000 | -3,78 | 192.462.000 | 178.381.000 |
| 2023-06-30 | 10-Q | 1.000.000 | -11.140.000 | -12,73 | 78.638.000 | -61.460.000 |
| 2023-03-31 | 10-Q | 476.000 | -7.089.000 | -8,10 | 83.441.000 | -50.820.000 |
| 2022-12-31 | 10-K | -28.476.000 | -32,57 | 83.110.000 | -44.368.000 | |
| 2022-09-30 | 10-Q | 1.173.000 | -7.784.000 | -8,90 | 164.123.000 | -34.754.000 |
| 2022-06-30 | 10-Q | -5.695.000 | -0,29 | 175.121.000 | -27.481.000 | |
| 2022-03-31 | 10-Q | -4.881.000 | -0,39 | 194.385.000 | -22.065.000 | |
| 2021-12-31 | 10-K | -71.136.000 | -1,29 | 189.934.000 | -17.249.000 | |
| 2021-09-30 | 10-Q | -17.427.000 | -0,30 | 206.236.000 | 189.688.000 | |
| 2021-06-30 | 10-Q | -16.928.000 | -0,32 | 220.378.000 | 202.892.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 05.05.2026 | – | -0,85 |
| Q3 2025 | 30.09.2025 | 05.11.2025 | 396.000 USD | -0,97 |
| Q2 2025 | 30.06.2025 | 05.11.2025 | 193.000 USD | -0,88 |
| Q1 2025 | 31.03.2025 | 05.05.2026 | 1,2 Mio. USD | -0,82 |
| Q3 2024 | 30.09.2024 | 05.11.2025 | 2,2 Mio. USD | -0,74 |
| Q2 2024 | 30.06.2024 | 05.11.2025 | 1,9 Mio. USD | -0,51 |
| Q1 2024 | 31.03.2024 | 05.11.2025 | 874.000 USD | -0,54 |
| Q3 2023 | 30.09.2023 | 07.11.2024 | 924.000 USD | -3,78 |
| Q2 2023 | 30.06.2023 | 07.11.2024 | – | -12,73 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 05.05.2026 | 10-Q | 31.03.2026 | 35 Tage | SEC » |
| 09.03.2026 | 10-K | 31.12.2025 | 68 Tage | SEC » |
| 05.11.2025 | 10-Q | 30.09.2025 | 36 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 12.05.2025 | 10-Q | 31.03.2025 | 42 Tage | SEC » |
| 11.03.2025 | 10-K | 31.12.2024 | 70 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
| 08.08.2024 | 10-Q | 30.06.2024 | 39 Tage | SEC » |
| 09.05.2024 | 10-Q | 31.03.2024 | 39 Tage | SEC » |
| 21.03.2024 | 10-K | 31.12.2023 | 81 Tage | SEC » |
| 09.11.2023 | 10-Q | 30.09.2023 | 40 Tage | SEC » |
| 03.08.2023 | 10-Q | 30.06.2023 | 34 Tage | SEC » |
| 15.05.2023 | 10-Q | 31.03.2023 | 45 Tage | SEC » |
| 01.05.2023 | 10-K/A | 31.12.2022 | 121 Tage | SEC » |
| 23.03.2023 | 10-K | 31.12.2022 | 82 Tage | SEC » |
| 03.11.2022 | 10-Q | 30.09.2022 | 34 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 16.05.2022 | 10-Q | 31.03.2022 | 46 Tage | SEC » |
| 08.03.2022 | 10-K | 31.12.2021 | 67 Tage | SEC » |
| 04.11.2021 | 10-Q | 30.09.2021 | 35 Tage | SEC » |
| 05.08.2021 | 10-Q | 30.06.2021 | 36 Tage | SEC » |
| 06.05.2021 | 10-Q | 31.03.2021 | 36 Tage | SEC » |
| 03.03.2021 | 10-K | 31.12.2020 | 62 Tage | SEC » |
| 05.11.2020 | 10-Q | 30.09.2020 | 36 Tage | SEC » |
| 06.08.2020 | 10-Q | 30.06.2020 | 37 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 22.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 05.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 16.09.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 28.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 12.09.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 of this Current Report on Form 8-K regarding the Board of Directors and executive officers following the… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-13 | 3.028 | 86,15 | 260.862 |
| 2026-05-04 | 844 | 87,42 | 73.782 |
| 2026-04-27 | 1 | 87,39 | 87 |
| 2026-04-20 | 3.355 | 93,26 | 312.887 |
| 2026-04-15 | 1.724 | 94,91 | 163.625 |
| 2026-04-10 | 88 | 91,66 | 8.066 |
| 2026-04-06 | 1 | 86,00 | 86 |
| 2026-03-26 | 21.205 | 79,61 | 1.688.130 |
| 2026-03-19 | 100 | 78,86 | 7.886 |
| 2026-03-17 | 1.215 | 78,00 | 94.770 |
| 2026-03-12 | 1.563 | 85,84 | 134.168 |
| 2026-03-03 | 130 | 55,26 | 7.184 |
| 2026-02-23 | 27.775 | 49,56 | 1.376.529 |
| 2026-02-17 | 1.853 | 47,40 | 87.832 |
| 2026-02-09 | 45 | 50,75 | 2.284 |
| 2026-02-03 | 176 | 53,18 | 9.360 |
| 2026-02-02 | 526.695 | 53,39 | 28.120.246 |
| 2026-01-16 | 2.581 | 44,00 | 113.564 |
| 2026-01-15 | 306.925 | 46,29 | 14.207.558 |
| 2026-01-07 | 12 | 36,20 | 434 |
| 2025-12-23 | 1.848 | 43,77 | 80.887 |
| 2025-12-18 | 21.397 | 41,43 | 886.478 |
| 2025-12-15 | 9.428 | 42,13 | 397.202 |